article · Natural Product Research
aqueous extract (AEMV) on peripheral neuropathic pain induced by chronic constriction injury (CCI) of the sciatic nerve in mice. This research represents the first exploration of AEMV's therapeutic potential in neuropathic pain management. AEMV was initially analysed using HPLC MS/MS to identify its predominant compound, Marrubiin. Mice underwent CCI surgery to induce neuropathic pain. AEMV was administered orally and Clomipramine served as a positive control. Chronic administration of AEMV significantly attenuated thermal, mechanical, and cold sensitivity induced by CCI. It also promoted functional and histological recovery of the sciatic nerve.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1080/14786419.2024.2424403
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.